Ebook: Virtual drug commercialization

By AmerisourceBergen

Actionable guidance on overcoming the engagement barriers COVID-19 has presented

The success of a manufacturer’s product depends heavily on provider uptake, patient and provider access to the product, and demonstrating product value to payers. And while all these touchpoints may happen at various stages of the product life cycle, they’ve all been impacted by COVID-19.
 
Download now for actionable guidance on overcoming the engagement barriers COVID-19 has presented for the critical groups manufacturers want to reach: providers, payers, patients.
 
This ebook is presented in partnership with Pharmaceutical Executive.